RecruitingNot ApplicableNCT05802758

CFT-focused Mental Health Intervention With Exposure Training for Youngsters

Compassion-focused Mental Health Intervention With Exposure Training in Virtual Reality for Youngsters Living in an Institution


Sponsor

Helsinki University Central Hospital

Enrollment

144 participants

Start Date

Jan 1, 2023

Study Type

INTERVENTIONAL

Conditions

Summary

The aim of this study is to explore if individual CFT-based intervention with exposure training in virtual reality decreases conduct disorder symptoms and callous-unemoitonal traits , as well as increases subjective emotional welbeing among 15-to-20 year-old male prisoners and boys placed to state's residential schools. We will also study factors that may predict adherence to the intervention. These factors include mental well-being, motivation, and working alliance. In addition, we will evaluate the costs of the program.


Eligibility

Sex: MALEMin Age: 15 YearsMax Age: 20 Years

Inclusion Criteria2

  • Express conduct disorder psychopathology and psychopathic personality traits
  • Are placed to a prison or a state residential school for at least 9 months

Exclusion Criteria8

  • Females
  • Non-Finninsh-speaking
  • Remaining in the institution facility less than 9 months
  • Intellectual dissability
  • Presence of psychotic symptoms
  • Autism
  • History of epilepsy
  • Currently participating another psychotherapeutic intervention

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

BEHAVIORALPsychopathy.comp and training in virtual reality (VR)

Psychopathy.comp is a CFT-based manualized program of 20 sessions a 60 min, on a weekly basis. During the CFT-intervention, partipants try out their new skills in a tailored VR setting (x5)


Locations(2)

State Residential Schools

Helsinki, Finland

Prison and Probation Service of Finland

Helsinki, Finland

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT05802758


Related Trials